Quote from: Stephenie S on October 14, 2016, 07:29:18 PM
I didn't realize there was so much debate and difference of opinion on this idea of pill splitting
My partner is a pharmacist and insists that splitting or otherwise dividing the dose is pointless.
Half-life of the substance determines how frequently one should take it. Spiro's half life is around 12-16 hours, if I'm not mistaken.
QuoteSome believe that spiro doesn't really do very much other than antagonize testosterone by taking up space in T-receptors.
Also reduces testosterone by inhibiting its production at the stage of 17-hydroxylation
J Urol (Paris). 1981;87(9):635-8."The authors examined the influence of spironolactone on the concentration of testosterone, 5 alpha - dihydrotestosterone (DHT), progesterone, oestradiol (E2), LH, and FSH in 47 patients with prostatic hypertrophy, aged from 60 to 80 years. The control group consisted of 58 men of the same age."
"There was a considerable fall in the concentration of testosterone and of DHT and, at the same time, an increase in the concentration of progesterone, E2 and LH."
Arch Sex Behav. 1989 Feb;18(1):49-57."Following the initial visit, all 50 were begun on spironolactone and low-dose female hormone therapy. Despite high-dose estrogen treatment for more than 2 years, the mean testosterone (T) level for the CT group was not in the female range (169 +/- 193 ng/dl; normal 20-80). Spironolactone, in doses of 200-600 mg/day, lowered T to the female range in both groups after 12 months (CT 87 +/- 111 and SPS 49 +/- 41 ng/dl). This was achieved in the CT group despite decreases in estrogen dose and discontinuation of parenteral therapy."
Many transwomen can attest to T levels dropping under Spironolactone, when taken alone.
September 2012, Vol. 11, No. 5 , Pages 779-795 "Spironolactone acts as an anti-androgen by binding to the androgen receptors; lowers circulating testosterone by increasing its metabolic clearance and preventing a compensatory rise in testicular androgen synthesis; displaces estrogen from sex hormone-binding globulin (SHBG) and increases the peripheral conversion of testosterone to estrogen leading to elevated estradiol [12]. Estradiol levels decrease and testosterone increase significantly 3 – 6 months after stopping spironolactone [12]."
Ann Intern Med. 1977 Oct;87(4):398-403."blood estradiol levels in the spironolactone group (30 +/- 4 pg/ml) were significantly greater (P less than 0.01) than in the control group (13 +/- 2 pg/ml). These changes were primarily due to significant increases in the metabolic clearance rate of testosterone (P less than 0.02) and in the rate of peripheral conversion of testosterone into estradiol (P less than 0.001) in the spironolactone-treated group."
To be fair, other studies found no change in E2 or T following Spironolactone usage. So, it may depend on dose and individual.
QuoteEstradiol does most of the feminizing.
Androgen is a strong inhibitor of feminization (i.e. breast growth). In women with complete androgen insensitivity, their breasts grow significantly, even sometimes more than typical females despite low estrogen levels (around 50 pg/ml). This confirms androgen's role in suppressing female sexual secondary characteristics. Androgen will reduce estrogen sensitivity by reducing number of estrogen receptors.
Sobrinho LG, Kase N, Grunt JA (1971). Yale J Biol Med. 44 (2): 225–9."The serum concentration of estradiol in this patient, though far less than that found in normal males (around 30 pcg/ml.),15 was still enough to induce breast growth in the presence of androgen insensitivity. This phenomenon emphasizes the anti-estrogenic effect of androgens in mammary growth."
In men taking only anti-androgens, gynecomastia can be quite common despite no estrogen taken.
Clin Endocrinol (Oxf). 1994 Oct;41(4):525-30."Despite an increase in testosterone levels, excellent androgen blockade was obtained, as shown by a decrease in prostate specific antigen levels in 22/23 patients."
"mild gynaecomastia and/or breast tenderness were seen in 48 and 30% of cases respectively."
QuoteTaking spiro is supposed to reduce the amount of E needed because some react poorly to high doses.
This notion of "poor response to high doses" of E comes from a time when non bio-identical estrogens were used. Today, many studies have shown high doses of bio-identical E to be relatively safe, safer when taken non-orally. Times have changed.
Quote from: anjaq on October 15, 2016, 04:28:43 AM
Oral estradiol is converted to Estrone up to 90%. With patches it is 50%, with injections ist is 25%. Estrone is an estrogen, but it is not feminizing - so it gives you all the side effects but will not even show up in the usual blood tests, which only test for estradiol.
"It is often assumed that the high oestrone levels seen after oral intake of oestradiol
are disadvantageous as compared with the relatively low oestrone/oestradiol ratio
during transdermal treatment with oestradiol. It should be borne in mind that the
intrinsic hormonal activity of oestradiol is much greater than that of oestrone
and both can be interconverted in the target cells and hepatocytes according to
the equilibrium conditions. Oestrone and oestrone sulphate therefore represent
oestradiol metabolites and precursors at the same time and
the oestrone/oestra-
diol ratio is of no real clinical importance."
Also,
British Journal of Obstetrics
October 1984. Vol. 91 . pp. 1031-1036"during oral treatment, high concentrations of oestrone by competition and displacement may increase the amounts of free oestradiol."
But estrone may compete with estradiol at receptors, as well. Not so good.
QuoteSo the fear of high estradiol is basically mainly fueld because of taking oral estradiol or artificial estrogens.
More specifically, because of the high doses of non bio-identical estrogens as these are metabolized very slowly by the body, namely equine estrogens (found in Premarin) and ethinyl estradiol, which end up recirculating many times through the portal vein where coagulation factors are negatively impacted. Bio-identical estrogen is quickly metabolized and non-orally, there is less impact in the liver.